Matching slides 110,471
Current window 55,831-55,860
Pages 3,683
Rows per page 30
Component: Listclear collectionreset all

Component

55,831-55,860 of 110,471

filter-aware
02
2022 strategic update presentation2022 strategic update presentation · Goldman Sachs
Consulting deck Equity research Beat · Situation & Context1 hit
03
2022 strategic update presentation2022 strategic update presentation · Goldman Sachs
Consulting deck Equity research Beat · Situation & Context1 hit
05
This slide serves as a formal disclosure or institutional profile, likely for a CRA (Community Reinvestment Act) performance evaluation context.2022 strategic update presentation · Goldman Sachs
Consulting deck Equity research Beat · Situation & ContextLoop · Logic Chain1 hit
21
Contains footnotes referencing specific regulatory and data sources.2022 strategic update presentation · Goldman Sachs
Consulting deck Equity research Beat · Impact & Next Steps1 hit
23
This slide details the regulatory compliance process for public comment and summarizes the qualitative feedback received from community stakeholders.2022 strategic update presentation · Goldman Sachs
Consulting deck Equity research Beat · Impact & Next Steps1 hit
28
The slide combines high-level impact metrics with a narrative case study.2022 strategic update presentation · Goldman Sachs
Consulting deck Equity research Beat · Impact & Next StepsLoop · Golden Circle1 hit
30
Includes specific mention of $17 billion investment and regulatory compliance with NYDFS guidelines.2022 strategic update presentation · Goldman Sachs
Consulting deck Equity research Beat · Impact & Next StepsLoop · Golden Circle1 hit
33
Includes footnotes referencing specific data points and external sources.2022 strategic update presentation · Goldman Sachs
Consulting deck Equity research Beat · Solution & ApproachLoop · Golden Circle1 hit
73
This is a page from a regulatory disclosure document (Form ADV).asset and wealth management mn · Goldman Sachs
Consulting deck Equity research Beat · Evidence & Proof1 hit
78
Form ADV disclosure page.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research Beat · Evidence & Proof1 hit
145
This is a regulatory disclosure page from a Form ADV document.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research Beat · Impact & Next Steps1 hit
146
Page 146 of a Form ADV document.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research Beat · Impact & Next Steps1 hit
147
Form ADV page 147.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research Beat · Impact & Next Steps1 hit
149
This is a standard regulatory disclosure page defining key terminology for legal compliance.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research Beat · Impact & Next Steps1 hit
173
This appears to be a page from a regulatory filing (Form ADV).asset and wealth management mn · Goldman Sachs
Consulting deck Equity research 1 hit
174
This is a standard regulatory brochure supplement (Form ADV Part 2B).asset and wealth management mn · Goldman Sachs
Consulting deck Equity research 1 hit
175
Standard regulatory disclosure document (Form ADV Part 2B).asset and wealth management mn · Goldman Sachs
Consulting deck Equity research 1 hit
176
This is a standard Form ADV Part 2B brochure supplement.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research 1 hit
181
This is a standard regulatory disclosure document.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research 1 hit
183
This is a standard legal disclosure page, likely part of a larger document set.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research 1 hit
07
The slide emphasizes the bioerodible nature and small size of the insert compared to legacy technology.Eyepoint Goldman Sachs June 10 2025 · EyePoint Pharmaceuticals
Consulting deck Equity research 1 hit
08
The slide explains the mechanism of action (Vorolanib) and the delivery technology (Durasert E) for the product DURAVYU.Eyepoint Goldman Sachs June 10 2025 · EyePoint Pharmaceuticals
Consulting deck Equity research 1 hit
17
The slide uses a timeline-based study design framework.Eyepoint Goldman Sachs June 10 2025 · EyePoint Pharmaceuticals
Consulting deck Equity research 1 hit
23
Supplement-free is defined as patients who did not receive a supplement at any point during the study.Eyepoint Goldman Sachs June 10 2025 · EyePoint Pharmaceuticals
Consulting deck Equity research 1 hit
26
Eyepoint Goldman Sachs June 10 2025Eyepoint Goldman Sachs June 10 2025 · EyePoint Pharmaceuticals
Consulting deck Equity research 1 hit
27
Eyepoint Goldman Sachs June 10 2025Eyepoint Goldman Sachs June 10 2025 · EyePoint Pharmaceuticals
Consulting deck Equity research 1 hit
05
The slide uses a pie chart to illustrate the revenue contribution of four main business lines.Goldman Sachs Presentation Final · U.S. Bancorp
Consulting deck Equity research Beat · NeedLoop · Logic Chain1 hit
10
The slide uses a split-screen comparison layout to showcase two distinct product offerings.Goldman Sachs Presentation Final · U.S. Bancorp
Consulting deck Equity research Beat · Satisfaction1 hit
11
Goldman Sachs Presentation FinalGoldman Sachs Presentation Final · U.S. Bancorp
Consulting deck Equity research Beat · Satisfaction1 hit
15
Goldman Sachs Presentation FinalGoldman Sachs Presentation Final · U.S. Bancorp
Consulting deck Equity research Beat · Action1 hit